Pitman Roger K, Sanders Kathy M, Zusman Randall M, Healy Anna R, Cheema Farah, Lasko Natasha B, Cahill Larry, Orr Scott P
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA.
Biol Psychiatry. 2002 Jan 15;51(2):189-92. doi: 10.1016/s0006-3223(01)01279-3.
Preclinical considerations suggest that treatment with a beta-adrenergic blocker following an acute psychologically traumatic event may reduce subsequent posttraumatic stress disorder (PTSD) symptoms. This pilot study addressed this hypothesis.
Patients were randomized to begin, within 6 hours of the event, a 10-day course of double-blind propranolol (n = 18) versus placebo (n = 23) 40 mg four times daily.
The mean (SD) 1-month Clinician-Administered PTSD Scale (CAPS) score of 11 propranolol completers was 27.6 (15.7), with one outlier 5.2 SDs above the others' mean, and of 20 placebo completers, 35.5 (21.5), t = 1.1, df = 29, p =.15. Two propranolol patients' scores fell above, and nine below, the placebo group's median, p =.03 (sign test). Zero of eight propranolol, but six of 14 placebo, patients were physiologic responders during script-driven imagery of the traumatic event when tested 3 months afterward, p =.04 (all p values one-tailed).
These pilot results suggest that acute, posttrauma propranolol may have a preventive effect on subsequent PTSD.
临床前研究提示,在急性心理创伤事件后使用β-肾上腺素能阻滞剂进行治疗,可能会减轻后续创伤后应激障碍(PTSD)的症状。本初步研究探讨了这一假设。
患者在事件发生后6小时内被随机分组,开始为期10天的双盲普萘洛尔治疗(n = 18),每日4次,每次40 mg,与安慰剂组(n = 23)对照。
11名普萘洛尔治疗完成者1个月时临床医生用PTSD量表(CAPS)评分的均值(标准差)为27.6(15.7),其中有1名离群值比其他患者的均值高出5.2个标准差;20名安慰剂治疗完成者的评分为35.5(21.5),t = 1.1,自由度 = 29,p = 0.15。2名普萘洛尔治疗患者的评分高于安慰剂组中位数,9名低于中位数,p = 0.03(符号检验)。3个月后进行创伤事件脚本驱动想象测试时,8名普萘洛尔治疗患者中无一人出现生理反应,而14名安慰剂治疗患者中有6人出现生理反应,p = 0.04(所有p值均为单尾)。
这些初步结果提示,创伤后即刻使用普萘洛尔可能对后续PTSD具有预防作用。